Name | Ulipristal Acetate-d6 |
---|---|
Synonyms |
Estra-4,9-dien-3-one, 17-acetyl-17-(acetyloxy)-11-[4-(dimethyl-d3-amino)phenyl]-, (11β,17α)-
Ulipristal Acetate-d6 (11β)-11-(4-{Bis[(2H3)methyl]amino}phenyl)-3,20-dioxo-19-norpregna-4,9-dien-17-yl acetate |
Description | Ulipristal acetate-d6 is deuterium labeled Ulipristal acetate. Ulipristal acetate (CDB-2914) is an orally active, selective progesterone receptor modulator (SPRM). Ulipristal acetate stimulates the autophagic response selectively in leiomyoma cells. Ulipristal acetate has the potential for benign gynecological conditions treatment, such as uterine myoma[1][2]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 640.1±55.0 °C at 760 mmHg |
Molecular Formula | C30H31D6NO4 |
Molecular Weight | 481.66 |
Flash Point | 340.9±31.5 °C |
Exact Mass | 481.309906 |
LogP | 4.48 |
Vapour Pressure | 0.0±1.9 mmHg at 25°C |
Index of Refraction | 1.594 |